本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

美鼎生物

33.97
0.0000
成交量:- -
成交額:2.18億
市值:14.95億
市盈率:35.39
高:33.97
開:33.97
低:33.97
收:33.97
資料載入中...
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/02/03

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/02

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/02/02

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/02/02

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/02/02

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/02/02

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/02/02

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/02/02

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/02/02

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/02/02

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/02/02

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/02/02

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/02/02

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/02/01

重要事件披露

8-K - Current report
2023/01/31

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/01/27

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/01/10

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/12

重要事件披露

8-K - Current report